<!DOCTYPE html>
<html lang="en">

<head>
   <meta charset="UTF-8">
   <meta http-equiv="X-UA-Compatible" content="IE=edge">
   <meta name="viewport" content="width=device-width, initial-scale=1.0">
   <title>Document</title>
   <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.1.2/css/all.min.css">
   <link href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;600&display=swap" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/4.6.0/css/bootstrap.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/OwlCarousel2/2.3.4/assets/owl.carousel.min.css" rel="stylesheet">
    <link rel="stylesheet" href="style2.css">
    
</head>
<style>
   .content {
      display: flex;
      justify-content: center;
      width: 100%;
      align-items: center;
      flex-wrap: wrap;
      margin-top: 1rem;
   }

   .contnetimg {
      width: 28%;
      border: 1px solid black;
      min-width: 300px;

   }

   .contentparas {
      font-family: 'Lucida Sans', 'Lucida Sans Regular', 'Lucida Grande', 'Lucida Sans Unicode', Geneva, Verdana, sans-serif;
      justify-content: baseline;
      width: 90%;
      margin-left: 1rem
   }

   .heads {
      font-size: 23px;
      margin-top: 2rem;
      flex-wrap: wrap;
      justify-content: center;
      text-align: center;
      align-items: center;
      width: 80%;

   }

   .para {
      margin-top: 1rem;
      font-family: sans-serif;
      font-size: 18px;
      font-weight: 600;
      width: 100%;
      flex-wrap: wrap;
   }

   @media (max-width:400px) {
      .para {
         width: 100%;
      }

      .heads {
         justify-content: center;
         width: 90%;
         text-align: center;
         align-items: center;
         flex-wrap: wrap;
      }
   }

   .head3 {
      justify-content: center;
      display: flex;
      text-align: center;
      width: 100%;
      align-items: center;
      font-size: 23px;
      margin-top: 2rem;
      flex-wrap: wrap;
      justify-content: center;
      text-align: center;
      align-items: center;


   }
</style>

<body>

  
   <div class="logo">
      <a href="#"><span style="color: black; font-size: 40px;">OBGYNI</span><span style="color:red ; font-size: 40px ;"> NSIGHT </span></a>
   </div>
  <header class="header">
      <div class="container">
          <div class="row align-items-center justify-content-between">
              
              <button type="button" class="nav-toggler">
               <span style="margin-top: -0.5rem;"><i class="fa-solid fa-bars"></i></span>
              </button>
              <nav class="nav">
                <ul>
                  <li><a href="index.html" class="active">Home</a></li>
                  <li><a href="webinar.html">Webinars</a></li>
                  <li><a href="educationvido.html">Educational video</a></li>
                  <li><a href="index.html">Conditions</a></li>
                  <li><a href="#">Contact</a></li>
               
               </ul>
              </nav>
          </div>
      </div>
   </header>

  
     
     
   <div class="condion">
      <h1>Menstrual Disorder</h1>
   </div>


   <div class="head3">
      <p>
         <b>
            Treatment of recurrent vulvovaginal candidiasis

            :</b>
      </p>
   </div>

   <div class="content">
      <div class="contnetimg">
         <img src="md6.webp" alt="">

      </div>


      <div class="contentparas">


         <div class="para">
            Patients with recurrent vulvovaginal candidiasis (RVVC, defined as ≥3 culture-confirmed episodes in ≤12
            months) who do not respond to oral flother treatment options. In an industry-sponsored trial comparing
            treatment and maintenance with either oteseconazole (a novel azole) or fluconazole/placebo in 185 females
            with active RVVC, fewer patients receiving oteseconazole experienced ≥1 culture-confirmed candidiasis
            episodes during the 48-week maintenance phase compared with fluconazole/placebo (5 versus 42 percent,
            respectively). Where available, oteseconazole is a therapeutic option for patients with culture-confirmed
            RVVC who do not respond to fluconazole therapy and who are not pregnant, attempting pregnancy, or lactating.
            uconazole therapy have had few
         </div>
      </div>




      <div class="heads">

         <b>
            Oleoylethanolamide Reduces Dysmenorrhea Pain and Oxidative Stress in Girls :</b>
      </div>
      <div class="content">
         <div class="contnetimg">
            <img src="md1.webp" alt="">

         </div>


         <div class="contentparas">


            <div class="para">
               <p>In this study, girls with primary dysmenorrhea were used to assess how oleoylethanolamide (OEA)
                  affected oxidative stress and inflammatory markers. The patients were divided into two groups at
                  random and given either a placebo or a pill containing 125 mg of OEA daily (n = 22). At the start and
                  conclusion of the experiment, researchers assessed the subjects' levels of pain intensity, total
                  antioxidant capacity (TAC), malondialdehyde (MDA), C-reactive protein (CRP), and tumour necrosis
                  factor alpha (TNF-).
                  In comparison to the placebo group, oral OEA intake for 60 days substantially enhanced TAC (p = 0.022)
                  and reduced menstrual discomfort. The usage of this supplement can be introduced as an alternative
                  therapy to minimise the use of anti-inflammatory medicines because OEA has been shown to diminish
                  menstrual discomfort. The differences between the factors under examination at the beginning and the
                  conclusion of the study were not statistically significant.
               </p>
            </div>
         </div>



         <div class="heads">

            <b>
               Increased Calorie Intake to Reverse Energy Deficiency in Exercising Women: Impact on Bone and Menstrual
               Cyclicity
            </b>
         </div>
         <div class="content">
            <div class="contnetimg">
               <img src="md2.jpg" alt="">

            </div>


            <div class="contentparas">


               <div class="para">
                  <p>The randomised controlled REFUEL study examined how exercising women with menstrual irregularities
                     affected bone health and menstrual function.

                     Oligomenorrhea/amenorrhea (Oligo/Amen) - afflicted women were randomised to either
                     the intervention group, who increased energy intake by 20% to 40% over baseline for a 12-month
                     period, or the control group, which which did not. In contrast to the control group,
                     increasing dietary energy intake increased weight, body fat, and menstruation frequency, but did
                     not enhance bone mineral density.

                     The 12 month intervention could have been too brief, because the increase in calorie
                     intake wasn't enough to boost oestrogen levels, menstruation frequency, or a BMD.
                     Results: Over the course of a year, exercising women with oligomenorrhea/amenorrhea showed
                     improvements in their energy status, body mass (2.6 0.4 kg), femoral neck aBMD, and insulin-like
                     growth factor 1 (37.4 14.6 ng/mL). At month 6, both groups showed a decline in total hip areal bone
                     mineral density (aBMD) and a higher chance of menstruation (P 0.05).

                  </p>
               </div>
            </div>

            <div class="heads">

               <b>
                  Music and Premenstrual Symptoms and Quality of Life </b>
            </div>
            <div class="content">
               <div class="contnetimg">
                  <img src="md3.jfif" alt="">

               </div>


               <div class="contentparas">


                  <div class="para">
                     <p>The goal of this study was to demonstrate how music therapy may improve women's quality of life
                        and lower premenstrual syndrome levels.
                        Single-blinded randomised controlled trial was used in the investigation, which involved 97
                        college students. Women over the age of 20 who were premenopausal made up the participants.
                        The World Health Organization quality of life questionnaire (WHOQOL-BREF) and the Premenstrual
                        Syndrome Scale (PMSS) were assessed using the music therapy and control groups. The women in the
                        experimental groups had considerably lower premenstrual syndrome levels and
                        better quality of life right after the intervention.
                     </p>
                  </div>
               </div>

               <div class="heads">

                  <b>

                     Auriculotherapy in the Cares to the Premenstrual Syndrome
                  </b>
               </div>
               <div class="content">
                  <div class="contnetimg">
                     <img src="doctor-checking-pregnant-woman-tummy-with-stethoscope_85574-4709.webp" alt="">

                  </div>


                  <div class="contentparas">


                     <div class="para">
                        <p> The purpose of this study was to investigate at how auriculotherapy affected the severity of
                           both physical and emotional PMS symptoms.
                           Ninety-one women were randomly assigned to Auriculotherapy (AG), Placebo (PG), and Control
                           (CG) groups. microneedles were placed in seven points related to PMS symptoms (Anxiety;
                           Endocrine; Muscle relaxation; Analgesia; Kidney; Shen Men; and Sympathetic).
                           AG and PG showed significantly lower scores of PMM symptoms, musculoskeletal pain, and
                           quality of life and follow-up analysis, the significance was observed only in PG.
                           To reduce the physical and emotional symptoms of PMS, auriculotherapy can be performed as an
                           adjunctive therapy.

                        </p>
                     </div>
                  </div>





               </div>


               <footer class="footer">           
                  <div class="container">
               <div class="row">
                  <div class="footer-col">
                     <h4>company</h4>
                     <ul>
                        <li><a href="#">about us</a></li>
                        <li><a href="#">our services</a></li>
                        <li><a href="webinar.html">our Webinars</a></li>
                        <li><a href="educationvido.html">Educational videos</a></li>
                     </ul>
                  </div>
                  <div class="footer-col">
                     <h4>get help</h4>
                     <ul>
                        <li><a href="#">FAQ</a></li>
                        <li><a href="#">Contact us</a></li>
          
                     </ul>
                  </div>
                  <div class="footer-col">
                     <h4>online shop</h4>
                     <ul>
                        <li><a href="infertility.html">infertility</a></li>
                        <li><a href="pregnancy.html">pregnancy</a></li>
                        <li><a href="prgcomplcation.html">Pregnancy Complication</a></li>
                        <li><a href="menopause.html">menopause</a></li>
                        <li><a href="endromentsr.html">endometriosis</a></li>
                        <li><a href="menstrualdisorder.html">menstrual disorder</a></li>
                     </ul>
                  </div>
                  <div class="footer-col">
                     <h4>follow us</h4>
                     <div class="social-links">
                        <a href="#"><i class="fab fa-facebook-f"></i></a>
                        <a href="#"><i class="fab fa-twitter"></i></a>
                        <a href="#"><i class="fab fa-instagram"></i></a>
                        <a href="#"><i class="fab fa-linkedin-in"></i></a>
                     </div>
                  </div>
               </div>
            </div>
        </footer>




</body>
<script>


const navToggler = document.querySelector(".nav-toggler"); 
  navToggler.addEventListener("click", navToggle);
   function navToggle() 
   { navToggler.classList.toggle("active");
    const nav = document.querySelector(".nav");
     nav.classList.toggle("open");
      if(nav.classList.contains("open")){ nav.style.maxHeight = nav.scrollHeight + "px"; }
  else{ nav.removeAttribute("style"); } }
</script>
</html>